Fateme Babaha: Pleasure to Present A Novel FVIII Gene Therapy Enhancer at ISTH 2026
Fateme Babaha, PhD in Pathology and Molecular Medicine at Queen’s University, shared on LinkedIn:
”It was a pleasure to present my research at the International Society on Thrombosis and Haemostasis (ISTH) 2026 Congress in Paris!
It had the opportunity to present my work, ‘Efficacy of AAV-mediated FVIII transgene expression employing a short enhancer element from the human F8 locus,’ and to connect with researchers and experts in the field of hemophilia and gene therapy.
In this study, we investigated a novel, compact 92-bp enhancer element from the human F8 locus and its potential to improve FVIII transgene expression for hemophilia A gene therapy.
I’m grateful to my supervisor Dr. David Lillicrap for his continued support and to everyone who stopped by my poster for the insightful discussions and questions.”
Stay updated with Hemostasis Today.
-
Oct 28, 2026, 14:56Elizabeth Shirley: COVID-19 Vaccines, Spike Protein and Nitric Oxide Bioavailability
-
Oct 28, 2026, 14:39David Ledger: Anticoagulation Advances as Factor XIa Inhibition Reaches a New Milestone
-
Oct 28, 2026, 14:37Advancing Liver Health in Haemophilia Care – EAHAD
-
Oct 28, 2026, 14:34The Changing Landscape of Anticoagulant Therapy – ISTH
-
Oct 28, 2026, 14:17Clusterin Regulates von Willebrand Factor Multimer Stability Through ADAMTS13 Inhibition
-
Oct 28, 2026, 14:14Mina Jarrahi: Platelet-Rich Fibrin for Periodontal Regeneration
-
Oct 28, 2026, 14:06Mohammed Alo: A Stent Treats the Blockage, Not the Underlying Disease
-
Oct 28, 2026, 13:58Vladimir Lemaire: When Blood Clots Affect Elite Athletes
-
Oct 28, 2026, 13:27M. Alejandro Mosso-Pani: Dengue in Florida – Why Platelet Function Matters